glp-1 and muscle loss Loss: Semaglutide, Tirzepatide & Lean Mass What Happens After GLP-1 Weight

These data suggest that inhibition of glucagon receptor signalling results in hepatic lipid accumulation

This may be similar to patients with diabetes with lower HbA1c having less change than those with higher HbA1c with anti-diabetes medications which dont cause hypoglycemia

Glucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistance

2024 These are not marginal effects

However, individual responses can vary, with some individuals experiencing changes sooner and others taking longer to see results

Weight loss across this period was stratified by quartiles of engagement (Quartiles of average total app opens at 40 weeks: Q1 = 244.7 , Q4 = 2,162.2)